Evidence map›Paper›PMID 40507875›Full record

ArticleInternational journal of molecular sciences2025

β-Hydroxybutyrate Reduces Body Weight by Modulating Fatty Acid Oxidation and Beiging in the Subcutaneous Adipose Tissue of DIO Mice.

Violeta Heras, Virginia Mela, Pallavi Kompella, Elena Rojano, Guillermo Paz-López, Lucia Hurtado-García, Almudena Ortega-Gomez, Maria José García-López, María Luisa García-Martín, Juan A G Ranea and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Violeta HerasInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
Virginia MelaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0001-7702-0972
Pallavi KompellaNucleus, Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA.
Elena RojanoInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0002-2678-710X
Guillermo Paz-LópezInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0009-0005-0069-5660
Lucia Hurtado-GarcíaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0009-0004-9059-3782
Almudena Ortega-GomezInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0002-3762-6934
Maria José García-LópezInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0003-0196-8243
María Luisa García-MartínInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0002-2257-7682
Juan A G RaneaInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
Francisco J TinahonesInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
Isabel Moreno-IndiasInstituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina, IBIMA Plataforma BIONAND, 29590 Málaga, Spain.ORCID 0000-0002-6121-151X

Funding

Instituto de Salud Carlos III (PI18/01160, PI21/01677)Junta de Andalucía PY20-00447Universidad de Málaga UMA-FEDERJA-116
6 · The paper itself

Abstract

β-hydroxybutyrate (BHB) serves as an alternative cellular fuel during states of low glucose availability, such as fasting or carbohydrate restriction, when the body shifts to using fats and ketone bodies for energy. While BHB has shown potential metabolic benefits, its mechanisms of action in the context of obesity are not fully understood. In this study, we examined the effects of BHB supplementation on subcutaneous adipose tissue (SAT) metabolism in a diet-induced obesity (DIO) mouse model. Adult male mice were first fed a high-fat diet for six weeks, followed by a standard diet with or without BHB supplementation for an additional six weeks. BHB supplementation led to significant body weight loss independent of food intake. This weight reduction was associated with decreased adipocyte differentiation, reflected by reduced peroxisome proliferator-activated receptor gamma (PPARγ) protein levels and lower uncoupling protein 1 (UCP1) expression, indicating altered SAT function. Transcriptomic analysis of SAT revealed upregulation of genes involved in fatty acid activation and transport (e.g.,

Indexed as

3-Hydroxybutyric AcidBody WeightFatty AcidsObesitySubcutaneous FatAdipocytesAnimalsDiet, High-FatLipid MetabolismMaleMiceMice, Inbred C57BLOxidation-ReductionPPAR gammaUncoupling Protein 13-Hydroxybutyric AcidFatty AcidsPPAR gammaUncoupling Protein 1adipose tissuefatty acid oxidationobesitySATthermogenesisweight lossβ-hydroxybutyrate

Identifiers

PMID40507875
PMCPMC12154550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.